Chintan Khandhedia

Sun Pharma (India) — India

Medicine · Health Sciences

3h-index30citations28works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Treatment and Management(7), Diabetes Management and Research(4), Diabetes, Cardiovascular Risks, and Lipoproteins(3), Blood Pressure and Hypertension Studies(3), Pharmaceutical Practices and Patient Outcomes(3)

Publications28 total

Prostate-Specific Antigen Response with Apalutamide and Its Correlation with Clinical Outcomes in Metastatic Castration Sensitive Prostate Cancer: A Review
Indian Journal of Medical and Paediatric Oncology·2026Open Access
A comparative pharmacokinetic evaluation of two aqueous progesterone 25 mg injections in healthy postmenopausal women under fasting conditions: An open‐label, balanced, randomized, two‐treatment, two‐period, two‐sequence, single‐dose, crossover bioequivalence study
Clinical Pharmacology in Drug Development·2026Open Access
A real-world retrospective electronic medical record (EMR)-based study to evaluate effectiveness and tolerability of Ticagrelor in Indian patients with Acute coronary Syndrome (ACS)
Indian Heart Journal·2025Open Access
Comparative Pharmacokinetic Assessment of Once-Daily Extended-Release and Twice-Daily Amantadine Formulations in Healthy Male Subjects Under Fasting Conditions
Clinical Drug Investigation·2025Open Access
Role of Brivaracetam on Quality of Life in Patients with Partial Onset Seizures: A Review of the Literature
International Journal of Epilepsy·2025Open Access
Role of Adjunctive Levetiracetam in Children with Partial-Onset Seizures: A Review of Literature
International Journal of Epilepsy·2025Open Access
Effectiveness and tolerability of acebrophylline in patients with chronic obstructive pulmonary disease: a real-world retrospective study from electronic medical records
2025
Assessment of Burden of Partial Response to Standard Doses of Proton Pump Inhibitors in Patients with Clinically Diagnosed Gastroesophageal Reflux Disease: A Real-World Evidence Study in India
Drugs - Real World Outcomes·2025Open Access
Durability of glycemic response with FDC of sitagliptin and metformin in treatment naive T2DM indian patients from a real-world retrospective EMR based study
Endocrine Abstracts·2025
Assessment of atherosclerotic cardiovascular disease (ASCVD) risk using ASCVD risk estimator plus in indian patients with type 2 diabetes - a subgroup analysis from real-world, retrospective study
Endocrine Abstracts·2025
EFFECTIVENESS & TOLERABILITY OF METOPROLOL ER, TELMISARTAN & CHLORTHALIDONE FDC IN PATIENTS OF ESSENTIAL HYPERTENSION WITH STABLE CAD IN INDIA: REAL WORLD RETROSPETIVE STUDY
Journal of Hypertension·2025
EFFICACY AND SAFETY OF METOPROLOL+TELMISARTAN FDC IN ESSENTIAL HYPERTENSION: TREATMENT ON VARIABILITY INDEX AND SMOOTHNESS INDEX ANALYSES ASSESSED BY AMBULATORY BP MONITORING
Journal of Hypertension·2025
Exploring the Role of Sitagliptin in the Management of Type 2 Diabetes Mellitus for the Elderly: A Narrative Review.
PubMed·2025
Sitagliptin as an Add-on Therapy to Other Glucose-lowering Agents in Patients with Type 2 Diabetes Mellitus: A Narrative Review.
PubMed·2025· 2 cited
Revisiting the Cardiorenal Safety of Sitagliptin in Type 2 Diabetes Mellitus: A Literature Review.
PubMed·2025
Efficacy and Safety of a Topical Formulation Containing Trihydroxybenzoic Acid Glucoside and α‐Arbutin, Applied Along With a Sunscreen: A Noncomparative, Prospective, Interventional Study in Indian Females With Facial Melasma or Dark Spots
Journal of Cosmetic Dermatology·2025· 1 citedOpen Access
Assessment of Atherosclerotic Cardiovascular Disease Risk using Atherosclerotic Cardiovascular Disease Risk Estimator Plus in Indian Patients – A Real-world, Retrospective Study from Electronic Medical Records
Indian Heart Journal·2024· 1 citedOpen Access
Survey to understand current management practices among healthcare professionals for Indian patients with dyslipidemia (Control survey)
Indian Heart Journal·2024Open Access
Effectiveness of dapagliflozin and sitagliptin fixed dose combination in indian patients with type 2 diabetes mellitus in real world settings: age stratified-analysis from a retrospective study
Endocrine Abstracts·2024
Real-world effectiveness of dapagliflozin and sitagliptin fixed-dose combination in indian patients with type 2 diabetes: a retrospective analysis of electronic medical records stratified by BMI
Endocrine Abstracts·2024· 1 cited
page 1 of 2Next →

Frequent Co-authors

Suyog Mehta(24), Shruti Dharmadhikari(23), Amey Mane(23), Neeraj Markandeywar(18), Prachi Ahire(13), Sadhna Joglekar(7), Vinay Kudrigikar(7), P. H. Devkare(4), Bharadwaja Pendurthi(4), Prakadeesh Bharathi(4), Arindam Pande(4), Pranav Sheth(3), Rama Kumari(3), Soumya Dutta(3), Susheel Reddy(3), Vijay Chile(3), Arthik Shetty(2), Archana Karadkhele(2), Gaurav Puppalwar(2), Amey Mane(2)